Recent Advances in Drug Delivery and Formulation · 6 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review examines patented compositions and manufacturing procedures for nanomaterials used as adjuvants in nasal vaccines. It concludes that nanoadjuvants can enhance vaccine efficacy by influencing antigen availability and are a core component of intellectual property for innovative mucosal vaccines.
The paper is a narrative review summarizing peer-reviewed literature on patented nanomaterial adjuvants for nasal vaccines. It discusses the properties of nanoadjuvants, such as their ability to affect immune response by influencing the amount of antigen reaching the immune system or its prolonged release. The authors note that nanometric adjuvants are often central to the intellectual property of these innovative vaccines.
